Rafaella Siang

Rafaella Siang

Auto-generated profile, based on publicly available information

Rafaella Siang

University Hospitals Coventry and Warwickshire NHS Trust

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
JMJoseph Mayer
Joseph Mayer
JAJaffar Al-Sheikhli
Jaffar Al-Sheikhli
MNMaria Niespialowska-Steuden
Maria Niespialowska-Steuden
IPIan Patchett
Ian Patchett
JWJames Winter
James Winter
TDTarvinder Dhanjal
Tarvinder Dhanjal
Differentiating near-field (NF) and far-field (FF) electrograms (EGMs) is crucial in identifying critical arrhythmogenic substrate during ventricular tachycardia (VT) ablation. A novel algorithm annotates NF-fractionated signals enabling EGM peak frequency (PF) determination using wavelet transformation. This study evaluated the algorithms’ effectiveness in identifying critical components of the VT circuit during substrate mapping. A multicentre, international cohort undergoing VT ablation was investigated. VT activation maps were used to demarcate the isthmus zone (IZ). Offline analysis was performed to evaluate the diagnostic performance of low-voltage area (LVA) PF substrate mapping. A total of 30 patients encompassing 198 935 EGMs were included. The IZ PF was significantly higher in sinus rhythm (SR) compared to right ventricular paced (RVp) substrate maps (234 Hz (195–294) vs. 197 Hz (166–220); P = 0.010). Compared to LVA PF, the IZ PF was significantly higher in both SR and RVp substrate maps (area under curve, AUC: 0.74 and 0.70, respectively). The LVA PF threshold of ≥200 Hz was optimal in SR maps (sensitivity 69%; specificity 64%) and RVp maps (sensitivity 60%; specificity 64%) in identifying the VT isthmus. In amiodarone-treated patients (n = 20), the SR substrate map IZ PF was significantly lower (222 Hz (186–257) vs. 303 Hz (244–375), P = 0.009) compared to amiodarone-naïve patients (n = 10). The ≥200 Hz LVA PF threshold resulted in an 80% freedom from VT with a trend towards reduced ablation lesions and radiofrequency times. LVA PF substrate mapping identifies critical components of the VT circuit with an optimal threshold of ≥200 Hz. Isthmus PF is influenced by chronic amiodarone therapy with lower values observed during RV pacing.

20 December 2024 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Open access
PDF file
JAJaffar Al-Sheikhli
Jaffar Al-Sheikhli
PTPatrick Tran
Patrick Tran
RSRafaella Siang
Rafaella Siang
MNMaria Niespialowska-Steuden
Maria Niespialowska-Steuden
JMJoseph Mayer
Joseph Mayer
TDTarvinder Dhanjal
Tarvinder Dhanjal
Functional substrate mapping has emerged as an essential tool for electrophysiologists, overcoming many limitations of conventional mapping techniques and demonstrating favourable long-term outcomes in clinical studies. However, a consensus on the definition of ‘functional substrate’ mapping remains elusive, hindering a structured approach to research in the field. In this review, we highlight the differences between ‘functional mapping’ techniques (which assess tissue response to the ‘electrophysiological stress’ using short coupled extrastimuli) and those highlighting regions of slow conduction during sinus rhythm. We also address fundamental questions, including the optimal degree of electrophysiological stress that best underpins the critical isthmus and the role of wavefront activation in determining the most effective ablation site.

30 March 2026 in EP Europace
Verified
Journal Article
Open access
JAJaffar Al-Sheikhli
Jaffar Al-Sheikhli
XWXuezhe Wang
Xuezhe Wang
JMJoseph Mayer
Joseph Mayer
MMMohamed Anwar Mohamed
Mohamed Anwar Mohamed
SASyed Rizwan Ali
Syed Rizwan Ali
TDTarvinder Dhanjal
Tarvinder Dhanjal
Aims: Accuracy data for non-invasive electrocardiographic imaging (ECGi) in defining the arrhythmogenic substrate for scar-dependent ventricular tachycardia (VT) is lacking. This study evaluated the accuracy of ECGi mapping to localize the arrhythmogenic substrate and assessed the relationship to myocardial scar, isthmus, exit, and successful ablation sites. Methods and results: A total of 48 VTs in 31 patients were mapped with both ECGi (View into Ventricular Onset, VIVO) and electro-anatomical maps (EAM) to define the arrhythmogenic substrate. Myocardial segments were assigned for the VT-exit site region (VT-ESR), isthmus region, successful ablation sites, and cardiac cross-sectional imaging defined scar using the ventricular AHA segment model and underwent blinded analysis. VT-ESR complete match (defined as exact AHA segment concordance between ECGi and EAM) was seen in 67% and partial match (defined as adjacent segments) in 21% of VTs. ECGi VT-ESR was located within or adjacent to cross-sectional imaging defined scar in 85% of VTs. The VT isthmus was within or adjacent to the ECGi VT-ESR in 77% of VTs. Successful ablation sites were within or adjacent to the ECGi VT-ESR in 82% of VTs. VIVO ECGi accuracy was not affected by cardiomyopathy type or VT cycle length. In identifying epicardial VT-ESR for ischaemic cardiomyopathy, VIVO ECGi had a sensitivity and specificity of 71.4% and 92.9%; for non-ischaemic cardiomyopathy 66.7% and 100%, respectively. Conclusion: ECGi mapping with VIVO can accurately predict the arrhythmogenic substrate for scar-dependent VT. Incorporation of ECGi mapping to conventional VT ablation workflows may improve procedural efficiency.

7 May 2026 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Open access
PDF file
MNMaria Niespialowska-Steuden
Maria Niespialowska-Steuden
John SilberbauerJohn Silberbauer
John Silberbauer
JAJaffar Al-Sheikhli
Jaffar Al-Sheikhli
RSRafaella Siang
Rafaella Siang
JMJoseph Mayer
Joseph Mayer
TDTarvinder Dhanjal
Tarvinder Dhanjal
Catheter ablation is the primary treatment for ventricular tachycardia (VT) in patients with structural heart disease. Unfortunately, its long-term success remains limited. Although mapping techniques have advanced considerably, optimal ablation indices remain essential but less well defined. This two-part comprehensive review bridges the gap between bench and bedside by evaluating methods, technologies, and VT-specific lesion parameters. Here, in part 1, we critically examined conventional and emerging techniques, including radiofrequency (RF), high-power short-duration ablation, temperature-controlled RF. In the accompanying paper, part 2, we focus on bipolar RF ablation, pulsed field ablation and ultra-low-temperature cryoablation, venous ethanol and needle ablation. Despite the growing set of tools available for VT operators, clinical data on the practical and safe creation of lesions remain scarce. The evidence supporting most of the techniques reviewed is limited. We emphasise the need for personalised ablation strategies based on substrate and myocardial anatomy and advocate for the development of future integrated, metric-driven technologies.

6 May 2026 in Arrhythmia and Electrophysiology Review
Verified
Journal Article
Open access
PDF file
MNMaria Niespialowska-Steuden
Maria Niespialowska-Steuden
John SilberbauerJohn Silberbauer
John Silberbauer
JAJaffar Al-Sheikhli
Jaffar Al-Sheikhli
RSRafaella Siang
Rafaella Siang
JMJoseph Mayer
Joseph Mayer
TDTarvinder Dhanjal
Tarvinder Dhanjal
Catheter ablation remains a cornerstone in the treatment of ventricular tachycardia (VT) in structural heart disease. Part 1 of this review focused on the principles and technical aspects of radiofrequency (RF) ablation. Part 2 explores alternative strategies designed to overcome the limitations of conventional RF, in particular, achieving transmurality in complex or deep intramuscular substrates. We critically evaluate the mechanisms, evidence and clinical applications of bipolar RF ablation, pulsed-field ablation (PFA), ultra-low-temperature cryoablation (ULTC) and venous ethanol and needle ablation. Despite the rapid expansion of the technological armamentarium, current clinical evidence remains limited. The data supporting long-term safety and durability are predominantly based on preclinical and small observational studies. We advocate for continued investigation into these specialised techniques to provide a more tailored, patient-specific approach to VT management.